annual ROE:
-12.08%-17.18%(-336.86%)Summary
- As of today (September 17, 2025), PCRX annual return on equity is -12.08%, with the most recent change of -17.18% (-336.86%) on December 31, 2024.
- During the last 3 years, PCRX annual ROE has fallen by -18.30% (-294.21%).
- PCRX annual ROE is now -108.74% below its all-time high of 138.16%, reached on December 31, 2009.
Performance
PCRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-16.08%-3.42%(-27.01%)Summary
- As of today (September 17, 2025), PCRX quarterly return on equity is -16.08%, with the most recent change of -3.42% (-27.01%) on June 30, 2025.
- Over the past year, PCRX quarterly ROE has dropped by -23.51% (-316.42%).
- PCRX quarterly ROE is now -104.08% below its all-time high of 394.44%, reached on March 31, 2011.
Performance
PCRX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PCRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -336.9% | -316.4% |
| 3 y3 years | -294.2% | -395.1% |
| 5 y5 years | -270.6% | -476.3% |
PCRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -294.2% | at low | -290.3% | at low |
| 5 y | 5-year | -140.5% | at low | -151.3% | at low |
| alltime | all time | -108.7% | +97.8% | -104.1% | +98.9% |
PCRX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -16.08%(+27.0%) |
| Mar 2025 | - | -12.66%(+6.0%) |
| Dec 2024 | -12.08%(-336.9%) | -11.94%(+11.2%) |
| Sep 2024 | - | -10.74%(-244.5%) |
| Jun 2024 | - | 7.43%(-12.1%) |
| Mar 2024 | - | 8.45%(+63.1%) |
| Dec 2023 | 5.10%(+141.7%) | 5.18%(+488.6%) |
| Sep 2023 | - | 0.88%(-249.2%) |
| Jun 2023 | - | -0.59%(-57.2%) |
| Mar 2023 | - | -1.38%(-164.8%) |
| Dec 2022 | 2.11%(-66.1%) | 2.13%(-24.7%) |
| Sep 2022 | - | 2.83%(-48.1%) |
| Jun 2022 | - | 5.45%(-0.9%) |
| Mar 2022 | - | 5.50%(-10.7%) |
| Dec 2021 | 6.22%(-79.2%) | 6.16%(-34.8%) |
| Sep 2021 | - | 9.45%(-68.2%) |
| Jun 2021 | - | 29.70%(+5.2%) |
| Mar 2021 | - | 28.22%(-10.0%) |
| Dec 2020 | 29.86%(-1016.0%) | 31.34%(+1.8%) |
| Sep 2020 | - | 30.79%(-1203.6%) |
| Jun 2020 | - | -2.79%(>+9900.0%) |
| Mar 2020 | - | -0.02%(-99.4%) |
| Dec 2019 | -3.26%(+1937.5%) | -3.26%(-593.9%) |
| Sep 2019 | - | 0.66%(-72.5%) |
| Jun 2019 | - | 2.40%(-2.0%) |
| Mar 2019 | - | 2.45%(-1631.3%) |
| Dec 2018 | -0.16%(-99.1%) | -0.16%(-89.1%) |
| Sep 2018 | - | -1.47%(-63.6%) |
| Jun 2018 | - | -4.04%(-67.3%) |
| Mar 2018 | - | -12.34%(-25.0%) |
| Dec 2017 | -17.10% | -16.45%(-21.0%) |
| Sep 2017 | - | -20.81%(-24.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | -27.55%(+18.3%) |
| Mar 2017 | - | -23.29%(+35.7%) |
| Dec 2016 | -17.35%(-1926.3%) | -17.16%(+3.1%) |
| Sep 2016 | - | -16.64%(+219.4%) |
| Jun 2016 | - | -5.21%(+229.7%) |
| Mar 2016 | - | -1.58%(-266.3%) |
| Dec 2015 | 0.95%(-107.4%) | 0.95%(-82.9%) |
| Sep 2015 | - | 5.55%(+133.2%) |
| Jun 2015 | - | 2.38%(-435.2%) |
| Mar 2015 | - | -0.71%(-94.3%) |
| Dec 2014 | -12.92%(-89.2%) | -12.44%(-66.1%) |
| Sep 2014 | - | -36.67%(-43.5%) |
| Jun 2014 | - | -64.91%(-36.6%) |
| Mar 2014 | - | -102.44%(-8.6%) |
| Dec 2013 | -119.34%(+30.3%) | -112.06%(+6.4%) |
| Sep 2013 | - | -105.29%(+12.4%) |
| Jun 2013 | - | -93.66%(+2.6%) |
| Mar 2013 | - | -91.31%(+14.0%) |
| Dec 2012 | -91.62%(+2.1%) | -80.11%(-14.2%) |
| Sep 2012 | - | -93.35%(-10.0%) |
| Jun 2012 | - | -103.73%(-29.9%) |
| Mar 2012 | - | -148.07%(-53.6%) |
| Dec 2011 | -89.76%(-260.0%) | -319.34%(-51.4%) |
| Sep 2011 | - | -657.44%(-53.9%) |
| Jun 2011 | - | -1426.38%(-461.6%) |
| Mar 2011 | - | 394.44%(+152.2%) |
| Dec 2010 | 56.11%(-59.4%) | 156.37%(-36.8%) |
| Sep 2010 | - | 247.36%(+154.7%) |
| Jun 2010 | - | 97.12%(+6.4%) |
| Mar 2010 | - | 91.31%(+34.6%) |
| Dec 2009 | 138.16%(-124.7%) | 67.82% |
| Dec 2008 | -558.91% | - |
FAQ
- What is Pacira BioSciences, Inc. annual return on equity?
- What is the all time high annual ROE for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual ROE year-on-year change?
- What is Pacira BioSciences, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly ROE year-on-year change?
What is Pacira BioSciences, Inc. annual return on equity?
The current annual ROE of PCRX is -12.08%
What is the all time high annual ROE for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual return on equity is 138.16%
What is Pacira BioSciences, Inc. annual ROE year-on-year change?
Over the past year, PCRX annual return on equity has changed by -17.18% (-336.86%)
What is Pacira BioSciences, Inc. quarterly return on equity?
The current quarterly ROE of PCRX is -16.08%
What is the all time high quarterly ROE for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly return on equity is 394.44%
What is Pacira BioSciences, Inc. quarterly ROE year-on-year change?
Over the past year, PCRX quarterly return on equity has changed by -23.51% (-316.42%)